Claude Nicaise

Claude Nicaise is recorded as Board Member at Chemomab Therapeutics Ltd. (CMMB), Chairman at Filana Therapeutics, Inc. (FLNA) and Board Member at Sarepta Therapeutics, Inc. (SRPT) since January 1, 2015. The newest filing on record that lists Claude Nicaise as Board Member at Chemomab Therapeutics Ltd. (CMMB) is dated April 28, 2022. The newest filing on record that lists Claude Nicaise as Chairman at Filana Therapeutics, Inc. (FLNA) is dated April 28, 2026. Claude Nicaise was last confirmed as Board Member at Gain Therapeutics, Inc. (GANX) in a filing dated April 28, 2023. Filana Therapeutics, Inc. reported in an 8-K filed December 11, 2023 that Claude Nicaise was appointed Class II director, effective December 6, 2023. Chemomab Therapeutics Ltd. is classified in the Biotechnology industry within the Healthcare sector. Filana Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Chemomab Therapeutics Ltd. includes Adi Mor (CEO and Board Member), Dale Pfost (CEO and Board Member), Dr. Adi Mor (CEO) and 7 others.